Thermo Fisher Scientific's Olink Platform Selected for World's Largest Human Proteome Study
Portfolio Pulse from
Thermo Fisher Scientific's Olink Explore Platform has been chosen for the UK Biobank Pharma Proteomics Project, the largest human proteomics study, to analyze over 5,400 proteins from 600,000 samples. This selection highlights Thermo Fisher's leadership in scientific research tools.
January 10, 2025 | 12:30 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Thermo Fisher Scientific's Olink Explore Platform has been selected for the UK Biobank Pharma Proteomics Project, marking a significant endorsement of its technology in a major scientific study.
The selection of Thermo Fisher's Olink Platform for a large-scale proteomics study by UK Biobank is a strong endorsement of its technology. This could enhance Thermo Fisher's reputation and demand for its products, likely leading to a positive impact on its stock price.
CONFIDENCE 95
IMPORTANCE 85
RELEVANCE 90